A SEIR model for control of infectious diseases with constraints by M. H. A. Biswas, L. T. Paiva, MdR de Pinho

“…We study the solution of such problems when mixed state control constraints are used to impose upper bounds on the available vaccines at each instant of time. We also explore the possibility of imposing upper bounds on the number of susceptible individuals with and without limitations on the number of vaccines available. …”
Get full text

Viruses and neurodegeneration: a growing concern by S. Shouman, N. Hesham, T. Z. Salem

“…The COVID-19 pandemic has raised concerns about whether vaccines are essential for preventing viruses or whether vaccines may play a part in exacerbating or accelerating NDDs. …”
Get full text

Exosomes, their sources, and possible uses in cancer therapy in the era of personalized medicine by Tomas Zemanek, Lubos Danisovic, Andreas Nicodemou

“…Their potential as anticancer vaccines arise from the capacity to carry antigens and major histocompatibility complex (MHC) molecules. …”
Get full text

African swine fever: one hundred years later by V. V. Makarov

“…Evidently, it is hardly possible to expect development of anti-ASF vaccines and particularly the vaccines capable of preventing and effectively protecting against ASF epizooty according to the general understanding without addressing these issues.…”
Get full text

Editorial by Jörg Tremmel, Markus Rutsche

“… While the unprecedented lockdown measures were at the heart of the debate in the first year of the pandemic, the focus since then has shifted to vaccination issues. The reason, of course, is that vaccines and vaccinations have become available by now. …”
Get full text

Protective potential of structural proteins of the SARS-CoV-2 virus in protecting against COVID-19 by Inna V. Dolzhikova, Daria M. Grousova, Ilya D. Zorkov, Anna A. Ilyukhina, Anna V. Kovyrshina, Olga V. Zubkova, Olga D. Popova, Tatiana A. Ozharovskaya, Denis I. Zrelkin, Daria M. Savina, Ekaterina G. Samokhvalova, Amir I. Tukhvatulin, Dmitry V. Shcheblyakov, Denis Yu. Logunov, Alexander L. Gintsburg

“…Introduction. Many different vaccines for the prevention of COVID-19 have received emergency use approval in the shortest possible time. …”
Get full text

A Five-Year Retrospective Study of Foot-and-Mouth Disease Outbreaks in Southern Africa, 2014 to 2018 by Elliot Mpolokang Fana, Sununguko Wata Mpoloka, Melvin Leteane, LaToya Seoke, Kelebogile Masoba, Mokganedi Mokopasetso, Aobakwe Rapharing, Tshephang Kabelo, Patricia Made, Joseph Hyera

“…Therefore, the vaccines are still fit-purpose for the control FMD in the region. …”
Get full text

The PB1 protein of H9N2 influenza A virus inhibits antiviral innate immunity by targeting MAVS for TRIM25-mediated autophagic degradationThe parent data and images support the find... by Jiawei Luo, Yiyuan Lu, Enqi Dai, Nianchun Yin, Ting Wang, Hongxi Qian, Qingrong Jiang, Xin Cao, Chunfeng Wang, Yan Zeng

Get full text

Cognitive authorities of COVID-19 information: educational differences and outcomes of trust in health experts and social media influencers in Finland by Sanna Malinen, Aki Koivula

“…Then, linear probability models were employed to analyse the factors shaping trust and determining vaccine intention. Finally, the analysis examined the indirect effects of trust in the association between education and vaccine uptake. …”
Get full text

Induction of Tolerance via the Sublingual Route: Mechanisms and Applications by Philippe Moingeon, Laurent Mascarell

“…The clinical efficacy of sublingual immunotherapy (SLIT) with natural allergen extracts has been established in IgE-dependent respiratory allergies to grass or tree pollens, as well as house dust mites. Sublingual vaccines have an excellent safety record, documented with approximately 2 billion doses administered, as of today, in humans. …”
Get full text

Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit by Eylem Kiral, Ayse Filiz Yetimakman

“…Routine use of meningococcal vaccines during childhood would be a better strategy for controlling IMD in both developing and developed countries.…”
Get full text

Covid-19 Detection from Chest X-Ray Images and Hybrid Model Recommendation with Convolutional Neural Networks by Furkan Eryılmaz, Hacer Karacan

“…The COVID-19 pandemic, which emerged at the end of 2019, continues to be effective. Although various vaccines have been developed, uncertainties remain over vaccine sharing, supply, storage and effect. …”
Get full text

Chaotic and Quasi-periodic Regimes in the Covid-19 Mortality Data by Ekrem Aydıner, Erkan Yılmaz

“…It is accepted that even if there are vaccines developed against the virus, it will never be possible to predict very complex spread dynamics and reach a spread pattern due to new variants and other parameters. …”
Get full text

The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children by Z Dangor, S A Madhi, H Zar, D Demopoulos

“…Recently, two new RSV prevention strategies have emerged: nirsevimab, a long-acting monoclonal antibody, and a maternal RSV vaccine. Both strategies have shown high efficacy in reducing RSV-LRTI hospitalisation in infants and are being considered for licensure in SA. …”
Get full text

Old and Recent Advances in Life Cycle, Pathogenesis, Diagnosis, Prevention, and Treatment of Malaria Including Perspectives in Ethiopia by Dejen Nureye, Solomon Assefa

“…Lack of clear understanding on the overall biology of Plasmodium has created a challenge in an effort to develop new drugs, vaccines, and preventive methods against malaria. However, three types of vaccines and a lot of novel compounds are under perclinical and clinical studies that are triggered by the occurrence of resistance among commonly used drugs and insecticides. …”
Get full text

Study of cultural properties of canine enteric coronavirus isolate in different cell cultures by A. A. Komarova, T. S. Galkina

“…In this regard, the prevention of this disease is still an acute problem; firstly this means the development of effective vaccines, which can provide are liable protection from the infection. …”
Get full text

Bovine Genital Campylobacteriosis by Max B. Irsik, Jan K. Shearer

“…Shearer, DVM, MS, describes this venereal disease of cattle formerly known as vibriosis, clinical findings and epidemiology, how to determine if there is a campylobacter problem in a herd, and the use of vaccines. Published by the UF Department of Veterinary Medicine -- Large Animal Clinical Sciences, March 2007. …”
Get full text

The Model of PPARγ-Downregulated Signaling in Psoriasis by Vladimir Sobolev, Anastasia Nesterova, Anna Soboleva, Evgenia Dvoriankova, Anastas Piruzyan, Dzerassa Mildzikhova, Irina Korsunskaya, Oxana Svitich

Get full text

Life Science 2.0: reframing the life science sector for ‘the benefit on mankind’ by Michaela Vallin, Göran Tomson, Beate Kampmann, Eivind Engebretsen, Stefan Swartling Peterson, Rhoda K. Wanyenze, Ole Petter Ottersen

“…The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. …”
Get full text